EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

THE IMPACT OF ANTENATAL CORTICOSTEROID ADMINISTRATION ON EARLY OUTCOME PARAMETERS AND LABORATORY FINDINGS IN NEONATES

Svjetlana Mikulić, Marjana Jerković Raguž

AFMN Biomedicine · 13.07.2026 · 43 (2) · 187-199

DOI: 10.65641/afmnai-2026-024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AFMN Biomedicine, online erschienen am 13.07.2026. Verfasst von Svjetlana Mikulić und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

<p style="text-align: justify;">This study evaluates the impact of antenatal corticosteroid (ACS) administration on early neonatal outcomes and laboratory parameters in preterm infants born at 28&ndash;34 gestational weeks. It assesses the effects of ACS on early morbidity, respiratory support, NICU admission, and metabolic changes reflected in laboratory parameters. A retrospective cohort study analysed medical records of preterm neonates born between January 2018 and July 2023. Neonatal outcomes were compared between ACS-exposed and non-exposed groups. Statistical analysis was performed using Chi-square and Fisher&rsquo;s exact tests (p &lt; 0.05). A total of 150 infants were included; 74 (49.3%) received ACS. No significant differences were found in birth weight, gestational age, Apgar scores, NICU admission, resuscitation needs, respiratory support, or early morbidity. ACS exposure was associated with a lower, though non-significant, rate of critical illness (8.1% vs. 18.4%). Serum magnesium levels were significantly higher in the non-ACS group (p = 0.003), likely reflecting maternal magnesium sulfate administration. ACS benefits appear more pronounced at lower gestational ages. In infants born after 32 weeks, ACS appears to have a limited impact on respiratory and early clinical outcomes, while overall prognosis is primarily determined by gestational maturity and baseline neonatal characteristics. These findings highlight the need for further research to refine ACS administration strategies, particularly for late preterm neonates.</p>

Zitieren

APA

Mikulić, S., & Raguž, M. J. (2026). THE IMPACT OF ANTENATAL CORTICOSTEROID ADMINISTRATION ON EARLY OUTCOME PARAMETERS AND LABORATORY FINDINGS IN NEONATES. AFMN Biomedicine, 43(2), 187-199. https://doi.org/10.65641/afmnai-2026-024

Vancouver

Mikulić S, Raguž MJ. THE IMPACT OF ANTENATAL CORTICOSTEROID ADMINISTRATION ON EARLY OUTCOME PARAMETERS AND LABORATORY FINDINGS IN NEONATES. AFMN Biomedicine. 2026;43(2):187-199. doi:10.65641/afmnai-2026-024

BibTeX
@article{Mikuli2026,
  author = {Mikulić, Svjetlana and Raguž, Marjana Jerković},
  title = {THE IMPACT OF ANTENATAL CORTICOSTEROID ADMINISTRATION ON EARLY OUTCOME PARAMETERS AND LABORATORY FINDINGS IN NEONATES},
  journal = {AFMN Biomedicine},
  year = {2026},
  volume = {43},
  number = {2},
  pages = {187--199},
  doi = {10.65641/afmnai-2026-024}
}
Kostenlos starten →